Trimetazidine Capsules
Indicated to manage stable angina pectoris and designed to alleviate cardiac ischemic symptoms.
Strengths: 20mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Vastarel MR
- Therapeutic class
Anti-anginal
- Pharmacological class
Piperazine derivative
- Contraindications
hypersensitivity to trimetazidine; Parkinson's disease; severe renal impairment
- Precautions and warnings
monitor for movement disorders; assess renal function in elderly
- Minor side effects
dizziness; headache; abdominal pain; diarrhoea
- Moderate side effects
nausea; vomiting; asthenia; rash
- Dosage forms
Modified-release capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Servier
- Onset Time
1–2 weeks
- Duration
12–24 hours
- Storage instructions
Store below 25°C in a dry place.
- Age restrictions
Use with caution in elderly patients.
- Pregnancy and breastfeeding
Pregnancy: Use is not recommended. Breastfeeding: Use is not recommended.
Serious side effects
parkinsonism — requires immediate medical attention; gait instability — requires immediate medical attention; tremor — requires immediate medical attention
Patient summary
Indicated to manage stable angina pectoris and designed to alleviate cardiac ischemic symptoms.
Mechanism of action
Trimetazidine is a metabolic anti-anginal agent that shifts myocardial metabolism from the oxidation of fatty acids to the oxidation of glucose, improving energy efficiency during ischemia.
Trimetazidine Capsules
Indicated to manage stable angina pectoris and designed to alleviate cardiac ischemic symptoms.
Editorial Notes
- Active ingredient(s): Trimetazidine
- Listed indication(s): Angina Pectoris
Available option
- 120 capsules - 20 mg1264-20-mg-15112